威高骨科 - Financials

威高骨科 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
+Revenue	1.5B	1.3B	2.1B	2.2B	1.8B	1.6B	1.2B	906.0M
Revenue Growth %	13.2%	-37.6%	-4.5%	18.1%	15.9%	30.0%	33.7%	--
Total Revenue	1.5B	1.3B	2.1B	2.2B	1.8B	1.6B	1.2B	906.0M
Cost Of Revenue	498.0M	430.0M	482.0M	405.0M	322.0M	275.0M	248.0M	235.0M
+Gross Profit	955.0M	854.0M	1.6B	1.7B	1.5B	1.3B	963.0M	671.0M
Gross Margin %	65.7%	66.5%	76.6%	81.2%	82.3%	82.5%	79.5%	74.1%
Total Operating Cost	1.2B	1.2B	1.4B	1.4B	1.2B	1.1B	832.0M	656.0M
Selling Expenses	481.0M	561.0M	711.0M	747.0M	631.0M	634.0M	457.0M	307.0M
Admin Expenses	92.4M	61.0M	75.6M	80.2M	92.2M	55.8M	46.5M	42.0M
Rd Expenses	120.0M	130.0M	118.0M	121.0M	82.5M	74.1M	48.1M	37.8M
Finance Expenses	-15.7M	-26.0M	-38.3M	-18.8M	-12.6M	-13.7M	-7.8M	-1.2M
+Operating Income	272.0M	131.0M	707.0M	811.0M	667.0M	513.0M	387.0M	255.0M
Operating Margin %	18.7%	10.2%	34.4%	37.7%	36.6%	32.6%	32.0%	28.1%
Non Operating Income	255,300	1.2M	392,600	350,500	355,000	211,100	224,500	334,100
Non Operating Expenses	1.0M	503,600	688,200	1.9M	997,100	1.7M	765,000	2.0M
Investment Income	26.8M	27.7M	27.6M	22.8M	2,826	967,000	--	--
Fair Value Change Income	317,400	126,100	--	--	--	--	--	--
Asset Disposal Income	6.4M	16,100	271,200	32,800	-421,600	30,100	--	1,200
Asset Impairment Loss	40.0M	30.8M	7.5M	3.7M	18.8M	10.7M	16.4M	16.7M
Other Income	11.4M	8.5M	13.6M	15.4M	8.8M	7.7M	7.1M	4.6M
Income Before Tax	271.0M	132.0M	706.0M	810.0M	666.0M	512.0M	386.0M	253.0M
Income Tax	42.7M	18.5M	106.0M	119.0M	104.0M	70.8M	62.1M	50.9M
+Net Income	228.0M	113.0M	600.0M	691.0M	562.0M	441.0M	324.0M	202.0M
Net Margin %	15.7%	8.8%	29.2%	32.1%	30.8%	28.0%	26.8%	22.3%
Net Income Attributable	224.0M	112.0M	601.0M	690.0M	558.0M	442.0M	324.0M	203.0M
Minority Interest	4.5M	777,600	-346,800	1.0M	3.3M	-534,700	-418,600	-717,100
Eps Basic	0.56	0.28	1.50	1.82	1.56	1.33	1.46	0.91
Eps Diluted	0.56	0.28	1.50	1.82	1.56	1.33	1.46	0.91

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash And Equivalents	1.7B	1.9B	2.6B	2.6B	1.6B	1.8B	806.0M	540.0M
Trading Financial Assets	90.5M	--	--	10.0M	--	--	--	--
Accounts Receivable	263.0M	302.0M	408.0M	344.0M	324.0M	332.0M	289.0M	250.0M
Notes Receivable	6.5M	16.0M	19.5M	18.5M	--	--	105.0M	45.0M
Notes And Accounts Receivable	270.0M	318.0M	427.0M	363.0M	324.0M	332.0M	394.0M	295.0M
Prepayments	16.1M	10.0M	10.4M	15.5M	3.2M	3.8M	15.8M	5.1M
Inventory	687.0M	754.0M	658.0M	565.0M	556.0M	421.0M	337.0M	304.0M
Total Current Assets	4.2B	4.3B	5.0B	4.7B	2.5B	2.6B	1.6B	1.2B
Fixed Assets	--	460.0M	425.0M	400.0M	363.0M	332.0M	338.0M	325.0M
Fixed Assets Total	426.0M	460.0M	425.0M	400.0M	363.0M	332.0M	338.0M	325.0M
Intangible Assets	99.7M	114.0M	100.0M	100.0M	106.0M	125.0M	131.0M	138.0M
Long Term Deferred Expenses	75.4M	100.0M	96.7M	92.8M	92.3M	86.6M	88.8M	79.4M
Total Non Current Assets	757.0M	833.0M	757.0M	704.0M	626.0M	587.0M	589.0M	565.0M
Total Assets	4.9B	5.1B	5.8B	5.4B	3.2B	3.2B	2.2B	1.7B
Accounts Payable	212.0M	300.0M	352.0M	338.0M	262.0M	208.0M	131.0M	82.3M
Advance Receipts	--	--	--	--	--	27.5M	19.9M	19.2M
Contract Liabilities	36.6M	92.0M	41.8M	28.1M	37.8M	--	--	--
Total Current Liabilities	858.0M	1.1B	768.0M	734.0M	611.0M	1.3B	361.0M	256.0M
Total Non Current Liabilities	126.0M	136.0M	114.0M	132.0M	99.7M	64.2M	61.9M	56.0M
Total Liabilities	985.0M	1.2B	882.0M	866.0M	710.0M	1.3B	423.0M	312.0M
Paid In Capital	400.0M	400.0M	400.0M	400.0M	359.0M	359.0M	222.0M	222.0M
Capital Reserve	1.3B	1.3B	2.4B	2.3B	1.0B	979.0M	615.0M	617.0M
Surplus Reserve	200.0M	200.0M	200.0M	200.0M	179.0M	146.0M	99.9M	68.2M
Retained Earnings	2.1B	2.0B	1.9B	1.6B	913.0M	388.0M	793.0M	500.0M
Minority Equity	9.7M	5.2M	147,600	6.1M	10.4M	7.0M	14.1M	5.8M
Equity Attributable	4.0B	3.9B	4.9B	4.5B	2.5B	1.9B	1.7B	1.4B
Total Equity	4.0B	3.9B	4.9B	4.5B	2.5B	1.9B	1.7B	1.4B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash From Sales	1.6B	1.7B	2.1B	2.3B	2.0B	1.7B	1.2B	963.0M
Tax Refunds Received	2.3M	17.1M	9.1M	--	--	--	--	--
Total Operating Cash Inflow	1.7B	1.8B	2.3B	2.4B	2.1B	1.8B	1.3B	989.0M
Cash Paid For Goods	389.0M	445.0M	417.0M	342.0M	310.0M	199.0M	166.0M	136.0M
Cash Paid To Employees	322.0M	327.0M	354.0M	307.0M	269.0M	330.0M	262.0M	202.0M
Taxes Paid	164.0M	250.0M	338.0M	369.0M	290.0M	291.0M	230.0M	168.0M
Total Operating Cash Outflow	1.4B	1.7B	1.8B	1.7B	1.5B	1.3B	971.0M	738.0M
Operating Cash Flow	274.0M	119.0M	509.0M	788.0M	644.0M	534.0M	324.0M	251.0M
Total Investing Cash Inflow	2.5B	1.2B	946.0M	399.0M	8.2M	482.0M	102,700	5,783
Total Investing Cash Outflow	2.7B	1.3B	1.1B	1.6B	54.6M	523.0M	64.3M	86.1M
Investing Cash Flow	-194.0M	-81.6M	-129.0M	-1.2B	-46.3M	-40.5M	-64.2M	-86.1M
Cash From Borrowings	8.5M	--	--	--	--	--	--	--
Dividends And Interest Paid	75.3M	164.0M	211.0M	5.3M	800.0M	31,800	--	99.6M
Total Financing Cash Inflow	8.5M	11.8M	4.3M	1.4B	24.7M	513.0M	10.7M	7.8M
Total Financing Cash Outflow	219.0M	936.0M	233.0M	51.0M	832.0M	31,800	4.5M	99.6M
Financing Cash Flow	-210.0M	-924.0M	-229.0M	1.4B	-808.0M	513.0M	6.2M	-91.8M
Net Change In Cash	-129.0M	-886.0M	150.0M	954.0M	-210.0M	1.0B	266.0M	73.3M
Ending Cash Balance	1.7B	1.8B	2.7B	2.6B	1.6B	1.8B	806.0M	540.0M
Capex	24.3M	43.0M	116.0M	112.0M	49.6M	28.9M	53.6M	37.5M